Navigation Links
Healthcare Companies Report Stock Price Updates, and Medical System Integration - Research Report on Johnson & Johnson, Geron, Ligand Pharmaceuticals, Masimo, and Capital Senior Living
Date:12/10/2013

ng full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

http://www.analystscorner.com/r/full_research_report/6e22_MASI

--

Capital Senior Living Corp. Research Report

On December 5, 2013, Capital Senior Living Corp.'s (Capital Senior Living) stock gained 4.55%, closing the day's trading at $23.42. For the past three trading days, the Company's stock increased 4.46%, compared to the Dow Jones Industrial Average Index which ended 1.17% lower over the same trading period. The Full Research Report on Capital Senior Living Corp. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

http://www.analystscorner.com/r/full_research_report/ca95_CSU

----

EDITOR NOTES:

  1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
  2. Information in this release is fact checked and produced on a best efforts basis and reviewed by Nidhi Vatsal, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
  3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
  4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco@EquityNewsNetwork.com.
  5. For any urgent concerns or inquiries, please contact us at compliance@EquityNewsNetwork.com.
  6. Are you a public company? Would you like to see similar coverage
    '/>"/>

SOURCE Analysts' Corner
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Actinium Pharmaceuticals to Present at the 24th Annual Oppenheimer Healthcare Conference
2. New Data Detailing Economic Impact of IV Acetaminophen in Treating Acute Pain to be Presented at Two Major Healthcare Conferences
3. Exel White Paper Identifies Need for Resilience and Reinvented Supply Chain in Life Sciences and Healthcare Industry
4. Atonomics and OMRON Healthcare Enter Agreement for Equity Investment
5. Nora Therapeutics Announces New Time for Presentation at the Oppenheimer 24th Annual Healthcare Conference
6. HeartWare Presentation At The Oppenheimer 24th Annual Healthcare Conference To Be Webcast
7. Questcor Pharmaceuticals to Present at the Oppenheimer Annual Healthcare Conference
8. Amgen To Present At The Oppenheimer 24th Annual Healthcare Conference
9. Ambit Announces Participation At Oppenheimer 24th Annual Healthcare Conference
10. Rigel to Present at Oppenheimer Healthcare Conference
11. Omeros to Present at Oppenheimer 24th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... /PRNewswire/-- LabStyle Innovations Corp. (DRIO), today announced that its Dario™ ... segment in Australia .  The Dario was ... and reimbursement approval in that country. 9 ... with diabetes. As a case in point, the news segment ... 13 year old boy with Type 1 diabetes and his ...
(Date:7/29/2015)... York , July 29, 2015 ... Transparency Market Research " Active Pharmaceutical Ingredients (API) Market ... Forecast 2014 - 2020 " the global active pharmaceutical ... 2013 and is anticipated to reach USD 185.9 billion ... the forecast period from 2014 to 2020. ...
(Date:7/29/2015)... 24, 2015 Research and Markets ( ... "Global Wound Care Markets (Twelve Country Analysis: ... Canada, China, India, Brazil, Australia, South Korea)" ... report provides a competitive market summary. The wound ... product offerings and product maturity. Several of the ...
Breaking Medicine Technology:LabStyle Innovations' Dario Diabetes Management Solution Featured on 9 News Australia 2LabStyle Innovations' Dario Diabetes Management Solution Featured on 9 News Australia 3Active Pharmaceutical Ingredients Market Expected to Reach USD 185.9 Billion Globally in 2020: Transparency Market Research 2Active Pharmaceutical Ingredients Market Expected to Reach USD 185.9 Billion Globally in 2020: Transparency Market Research 3Active Pharmaceutical Ingredients Market Expected to Reach USD 185.9 Billion Globally in 2020: Transparency Market Research 4Active Pharmaceutical Ingredients Market Expected to Reach USD 185.9 Billion Globally in 2020: Transparency Market Research 5Global Wound Care Markets 2015 2
... and Company (NYSE: LLY ) announced results ... genetic mutations and disable specific signaling pathways that can ... – a JAK2 inhibitor and a Hedgehog inhibitor – ... Research (AACR) 102nd Annual Meeting in Orlando, Fla.   ...
... N.C., April 4, 2011 Cardioxyl Pharmaceuticals, Inc. ... from studies of its lead clinical candidate, CXL-1020, ... Annual Scientific Session & Expo in New Orleans, ... demonstrate CXL-1020,s ability to work independently from other ...
Cached Medicine Technology:Two Novel Lilly Molecules Target Genetic Mutations That Can Lead to Cancer 2Two Novel Lilly Molecules Target Genetic Mutations That Can Lead to Cancer 3Two Novel Lilly Molecules Target Genetic Mutations That Can Lead to Cancer 4Cardioxyl Pharmaceuticals Presents Data On Its Clinical Candidate, CXL-1020, at the 60th Annual American College of Cardiology Scientific Session 2Cardioxyl Pharmaceuticals Presents Data On Its Clinical Candidate, CXL-1020, at the 60th Annual American College of Cardiology Scientific Session 3Cardioxyl Pharmaceuticals Presents Data On Its Clinical Candidate, CXL-1020, at the 60th Annual American College of Cardiology Scientific Session 4Cardioxyl Pharmaceuticals Presents Data On Its Clinical Candidate, CXL-1020, at the 60th Annual American College of Cardiology Scientific Session 5
(Date:7/29/2015)... ... 29, 2015 , ... According to the Miami Herald on July ... mental health disorders. Acu-detox may begin taking off in the South Florida community as ... addiction. Although acupuncture is not a new practice, it is not widely used, but ...
(Date:7/29/2015)... ... July 29, 2015 , ... Orthopedic surgeons at Lourdes Medical Center of ... Rotator Cuff System, a new implant to treat a common source of shoulder pain ... regeneration of additional tendon tissue, which could allow for faster healing and a decreased ...
(Date:7/29/2015)... ... , ... We are privileged to announce that U.S. News & World Report has ... hospital in the nation for 2015-2016. This marks the 21st consecutive year that the USC ... is an honor to be included in the top 10 ophthalmology hospitals by U.S. News ...
(Date:7/29/2015)... CA (PRWEB) , ... July 29, 2015 , ... ... Honduras with the Hackett Hemwall Foundation in March, Steven W. Meier M.D., a ... bono prolotherapy treatments to qualifying patients with demonstrated financial need. , “We are ...
(Date:7/29/2015)... Madison, Wis. (PRWEB) , ... July 29, 2015 ... ... enrolled its first two patients in a Clinical Performance Study for the Invisiport ... includes 4.4 and 6 French catheter options, offers a less invasive, patient-friendly alternative ...
Breaking Medicine News(10 mins):Health News:Miami Drug Rehab Introduces Acupuncture to Line of Holistic Healing for Addiction 2Health News:Miami Drug Rehab Introduces Acupuncture to Line of Holistic Healing for Addiction 3Health News:Lourdes Orthopedics First in NJ to Offer Bioinductive Implant for Rotator Cuff Repair 2Health News:Lourdes Orthopedics First in NJ to Offer Bioinductive Implant for Rotator Cuff Repair 3Health News:21 Years & Counting: The USC Eye Institute Ranks in the Top 10 Ophthalmology Hospitals in America 2Health News:21 Years & Counting: The USC Eye Institute Ranks in the Top 10 Ophthalmology Hospitals in America 3Health News:Orthopedic Surgeon Announces New Pro Bono Prolotherapy and Regenerative Medicine Clinic for Underserved Communities in Los Angeles 2Health News:Stealth Therapeutics Inc. Enrolls First Patients in a Clinical Performance Study for the Invisiport Product Line 2Health News:Stealth Therapeutics Inc. Enrolls First Patients in a Clinical Performance Study for the Invisiport Product Line 3
... Hamilton, co-author of Beverly Hills Beauty Secrets: A Prominent Dermatologist and ... 2009), brings you a bolder butt and tighter knees with his ... ... -- Stimulated by the J-LO/Beyonce phenomena, our aesthetic culture appears to ...
... issue of the Journal of Clinical Sleep Medicine ... and fatigue in cancer patients. The results indicate that ... improve both pain and fatigue in this patient population. ... reported having trouble sleeping, with 26 percent reporting moderate ...
... Drugs and radiotherapy given for cancer can cause ... mouth sores, dermatitis, and menopausal symptoms. Around a ... including homeopathic medicines, to try to reduce these ... controlled trials, Cochrane Researchers examined recent evidence for ...
... minimize damage, studies find , , TUESDAY, April 14 (HealthDay ... can be of great benefit in either preventing or treating ... be correlated with a lower risk of having a first ... another team in the Netherlands found that patients with a ...
... IDEXX Laboratories, Inc. (Nasdaq: IDXX ), has ... for Friday, April 24, at approximately 7:00 a.m. (eastern). The ... a.m. (eastern) on that day. Individuals can access a live ... IDEXX Web site, www.idexx.com . An archived ...
... areas for days, weeks , , TUESDAY, April 14 (HealthDay ... be a long-lasting local anesthetic for the treatment of ... The shot may also help patients with chronic pain, ... created the anesthetic by packaging the potent painkiller saxitoxin ...
Cached Medicine News:Health News:New Cosmetic Developments from Beverly Hills 2Health News:Study suggests that trouble sleeping leads to increased ratings of pain in cancer patients 2Health News:Homeopathic medicines: Can they help relieve side-effects of cancer therapy? 2Health News:Acetaminophen, Cholesterol Drugs May Help Fight Stroke 2Health News:Acetaminophen, Cholesterol Drugs May Help Fight Stroke 3Health News:Researchers Create Long-Acting Local Anesthetic 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: